Characteristics of the ICSRs (n = 1245)
| . | n . | % . |
|---|---|---|
| Sex (n = 1130) | ||
| Female | 572 | 51 |
| Male | 558 | 49 |
| Age (n = 893), y | ||
| Median age | 32 (1.58-58) | |
| Adults | 512 | 57 |
| Children | 381 | 43 |
| Country of primary source (n = 1245) | ||
| United States | 912 | 73.3 |
| Europe, including: | 222 | 17.8 |
| France | 57 | 4.6 |
| United Kingdom of Great Britain and Northern Ireland | 32 | 2.6 |
| Spain | 32 | 2.6 |
| Germany | 27 | 2.2 |
| Italy | 21 | 1.7 |
| Netherlands | 8 | 0.6 |
| Belgium | 7 | 0.6 |
| Switzerland | 5 | 0.4 |
| Portugal | 5 | 0.4 |
| Greece | 5 | 0.4 |
| Norway | 4 | 0.3 |
| Ireland | 4 | 0.3 |
| Hungary | 3 | 0.2 |
| Denmark | 3 | 0.2 |
| Austria | 3 | 0.2 |
| Slovenia | 2 | 0.2 |
| Czech Republic | 2 | 0.2 |
| Sweden | 1 | 0.1 |
| Finland | 1 | 0.1 |
| Japan | 61 | 4.9 |
| Australia | 29 | 2.3 |
| Canada | 10 | 0.8 |
| Turkey | 4 | 0.3 |
| Indonesia | 2 | 0.2 |
| India | 2 | 0.2 |
| Philippines | 1 | 0.1 |
| Mexico | 1 | 0.1 |
| Malaysia | 1 | 0.1 |
| Reporter qualification (n = 805) | ||
| Physician | 364 | 45 |
| Other health professional | 205 | 26 |
| Consumer/Non health professional | 163 | 20 |
| Pharmacist | 31 | 4 |
| Others | 42 | 5 |
| Serious adverse drug reactions (n = 1231) | ||
| Yes | 1123 | 91 |
| No | 108 | 9 |
| Fatal outcomes | 40 | — |
| . | n . | % . |
|---|---|---|
| Sex (n = 1130) | ||
| Female | 572 | 51 |
| Male | 558 | 49 |
| Age (n = 893), y | ||
| Median age | 32 (1.58-58) | |
| Adults | 512 | 57 |
| Children | 381 | 43 |
| Country of primary source (n = 1245) | ||
| United States | 912 | 73.3 |
| Europe, including: | 222 | 17.8 |
| France | 57 | 4.6 |
| United Kingdom of Great Britain and Northern Ireland | 32 | 2.6 |
| Spain | 32 | 2.6 |
| Germany | 27 | 2.2 |
| Italy | 21 | 1.7 |
| Netherlands | 8 | 0.6 |
| Belgium | 7 | 0.6 |
| Switzerland | 5 | 0.4 |
| Portugal | 5 | 0.4 |
| Greece | 5 | 0.4 |
| Norway | 4 | 0.3 |
| Ireland | 4 | 0.3 |
| Hungary | 3 | 0.2 |
| Denmark | 3 | 0.2 |
| Austria | 3 | 0.2 |
| Slovenia | 2 | 0.2 |
| Czech Republic | 2 | 0.2 |
| Sweden | 1 | 0.1 |
| Finland | 1 | 0.1 |
| Japan | 61 | 4.9 |
| Australia | 29 | 2.3 |
| Canada | 10 | 0.8 |
| Turkey | 4 | 0.3 |
| Indonesia | 2 | 0.2 |
| India | 2 | 0.2 |
| Philippines | 1 | 0.1 |
| Mexico | 1 | 0.1 |
| Malaysia | 1 | 0.1 |
| Reporter qualification (n = 805) | ||
| Physician | 364 | 45 |
| Other health professional | 205 | 26 |
| Consumer/Non health professional | 163 | 20 |
| Pharmacist | 31 | 4 |
| Others | 42 | 5 |
| Serious adverse drug reactions (n = 1231) | ||
| Yes | 1123 | 91 |
| No | 108 | 9 |
| Fatal outcomes | 40 | — |